| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 196.03 | 3.5% | 0.4% |
| Total Income | 196.03 | 3.5% | 0.4% |
| Expenditure | 181.41 | 2.9% | 3.8% |
| PBT | 6.10 | 68.8% | 24.8% |
| Net Profit | 1.12 | 91.3% | 71.8% |
| OPM | 7.46% | 5.74pp | 2.99pp |
| NPM | 0.57% | 5.75pp | 1.46pp |
| EPS | 0.00 | 100.0% | 100.0% |
GoodRx Holdings Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 8:13 am
Summary
GoodRx Holdings, Inc. announced the Company’s financial results for the three and nine months ended September 30, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this report.
Informational and educational content only. Not investment advice.